Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

99.70
Delayed Data
As of Dec 02
 -0.58 / -0.58%
Today’s Change
89.76
Today|||52-Week Range
177.93
-33.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues447.0K445.0K5.5M5.2M
 
 
 
 
 
Depreciation And Amortization632.0K684.0K860.0K643.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses88.7M77.7M82.8M87.6M
 
 
 
 
 
Research And Development44.4M37.4M41.3M43.8M
 
 
 
 
 
Total Operating Expenses89.3M78.3M83.6M88.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-88.9M-77.9M-78.1M-83.0M
 
 
 
 
 
Extraordinary Charge0.00-49.5M0.000.00
 
 
Interest Expense On Debt0.000.000.007.1M
 
 
Other Expenses637.0K726.0K796.0K1.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-88.3M-126.7M-77.3M-88.8M
 
 
 
 
 
Net Income-88.3M-126.7M-77.3M-88.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.4M24.5M24.6M24.7M
 
 
 
 
 
Shares To Calculate EPS Diluted24.4M24.5M24.6M24.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.62-$5.17-$3.14-$3.59
 
 
 
 
 
EPS Diluted-$3.62-$5.17-$3.14-$3.59